| 1 |
United States Renal Data System. 2022 USRDS Annual Data Report: Epidemiology of kidney disease in the United States[J]. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2022.
|
| 2 |
Wang L, Xu X, Zhang M, et al. Prevalence of chronic kidney disease in China: results from the sixth China chronic disease and risk factor surveillance[J]. JAMA Intern Med, 2023, 183(4): 298-310.
|
| 3 |
Drechsler C, Krane V, Ritz E, et al. Glycemic control and cardiovascular events in diabetic hemodialysis patients[J]. Circulation, 2009, 120(24): 2421-2428.
|
| 4 |
Thomas MC, Brownlee M, Susztak K, et al. Diabetic kidney disease[J]. Nat Rev Dis Primers, 2015, 1: 15018.
|
| 5 |
Mather A, Pollock C. Glucose handling by the kidney[J]. Kidney Int Suppl, 2011(120): S1-S6.
|
| 6 |
Hassanein M, Shafi T. Assessment of glycemia in chronic kidney disease[J]. BMC Med, 2022, 20(1): 117.
|
| 7 |
Galindo RJ, Beck RW, Scioscia MF, et al. Glycemic monitoring and management in advanced chronic kidney disease[J]. Endocr Rev, 2020, 41(5): 756-774.
|
| 8 |
Koga M. 1,5-Anhydroglucitol and glycated albumin in glycemia[J]. Adv Clin Chem, 2014, 64: 269-301.
|
| 9 |
Perlman JE, Gooley TA, McNulty B, et al. HbA1c and glucose management indicator discordance: A real-world analysis[J]. Diabetes Technol Ther, 2021, 23(4): 253-258.
|
| 10 |
Jung M, Warren B, Grams M, et al. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the atherosclerosis risk in communities study[J]. J Diabetes, 2018, 10(4): 276-285.
|
| 11 |
Ng JM, Cooke M, Bhandari S, et al. The effect of iron and erythropoietin treatment on the A1C of patients with diabetes and chronic kidney disease[J]. Diabetes Care, 2010, 33(11): 2310-2313.
|
| 12 |
Zelnick LR, Batacchi ZO, Ahmad I, et al. Continuous glucose monitoring and use of alternative markers To assess glycemia in chronic kidney disease[J]. Diabetes Care, 2020, 43(10): 2379-2387.
|
| 13 |
Navaneethan SD, Zoungas S, Caramori ML, et al. Diabetes management in chronic kidney disease: synopsis of the 2020 Kdigo clinical practice guideline[J]. Ann Intern Med, 2021, 174(3): 385-394.
|
| 14 |
ElSayed NA, Aleppo G, Aroda VR, et al. 6. Glycemic targets: standards of care in diabetes-2023[J]. Diabetes Care, 2023, 46(Suppl 1): S97-S110.
|
| 15 |
Ahmad I, Zelnick LR, Batacchi Z, et al. Hypoglycemia in people with type 2 diabetes and CKD[J]. Clin J Am Soc Nephrol, 2019, 14(6): 844-853.
|
| 16 |
Kazempour-Ardebili S, Lecamwasam VL, Dassanyake T, et al. Assessing glycemic control in maintenance hemodialysis patients with type 2 diabetes[J]. Diabetes Care, 2009, 32(7): 1137-1142.
|
| 17 |
Gai M, Merlo I, Dellepiane S, et al. Glycemic pattern in diabetic patients on hemodialysis: continuous glucose monitoring (CGM) analysis[J]. Blood Purif, 2014, 38(1): 68-73.
|
| 18 |
刘向阳, 郭航, 郭俊, 等. 应用扫描式葡萄糖监测系统监测透析治疗的合并糖尿病肾脏病的2型糖尿病患者血糖波动的价值[J]. 中华糖尿病杂志, 2021, 13(10): 960-965.
|
| 19 |
Joubert M, Fourmy C, Henri P, et al. Effectiveness of continuous glucose monitoring in dialysis patients with diabetes: the Dialydiab pilot study[J]. Diabetes Res Clin Pract, 2015, 107(3): 348-354.
|
| 20 |
Mirani M, Berra C, Finazzi S, et al. Inter-day glycemic variability assessed by continuous glucose monitoring in insulin-treated type 2 diabetes patients on hemodialysis[J]. Diabetes Technol Ther, 2010, 12(10): 749-753.
|
| 21 |
Williams J, Gilchrist M, Strain WD, et al. 24-h Glycaemic profiles in peritoneal dialysis patients and non-dialysis controls with advanced kidney disease[J]. Perit Dial Int, 2022, 42(5): 497-504.
|
| 22 |
Aouad LJ, Clayton P, Wyburn KR, et al. Evolution of glycemic control and variability after kidney transplant[J]. Transplantation, 2018, 102(9):1563-1568.
|
| 23 |
Diabetes C, Complications Trial Research G, Nathan DM, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus[J]. N Engl J Med, 1993, 329(14): 977-986.
|
| 24 |
Diabetes C, Complications Trial /Epidemiology of Diabetes I, Complications Research G, et al. Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow-up in the DCCT/EDIC[J]. Diabetes, 2015, 64(2): 631-642.
|
| 25 |
Group DER, de Boer IH, Sun W, et al. Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes[J]. N Engl J Med, 2011, 365(25): 2366-2376.
|
| 26 |
Fang HJ, Zhou YH, Tian YJ, et al. Effects of intensive glucose lowering in treatment of type 2 diabetes mellitus on cardiovascular outcomes: A meta-analysis of data from 58,160 patients in 13 randomized controlled trials[J]. Int J Cardiol, 2016, 218: 50-58.
|
| 27 |
Gubitosi-Klug RA, Braffett BH, White NH, et al. Risk of severe hypoglycemia in type 1 diabetes over 30 years of follow-up in the DCCT/EDIC study[J]. Diabetes Care, 2017, 40(8): 1010-1016.
|
| 28 |
Ramirez SP, McCullough KP, Thumma JR, et al. Hemoglobin A(1c) levels and mortality in the diabetic hemodialysis population: findings from the Dialysis Outcomes and Practice Patterns Study (DOPPS)[J]. Diabetes Care, 2012, 35(12): 2527-2532.
|
| 29 |
Kepenekian L, Smagala A, Meyer L, et al. Continuous glucose monitoring in hemodialyzed patients with type 2 diabetes: a multicenter pilot study[J]. Clin Nephrol, 2014, 82(4): 240-246.
|
| 30 |
王丽纯, 张晓菲, 胡文利, 等. 血糖波动与危重症患者预后相关性的临床研究[J/OL]. 中华临床医师杂志(电子版), 2011, 5(24): 7291-7294.
|
| 31 |
翟迎九, 郭美姿, 吕清, 等. 血糖波动对老年糖尿病患者氧化应激指标及胰岛β细胞功能的影响[J/OL]. 中华临床医师杂志(电子版), 2018, 12(9): 500-503.
|
| 32 |
宫倩倩, 吕肖锋, 张名扬, 等. 血糖波动对2型糖尿病患者下肢血管病变的影响[J/OL]. 中华临床医师杂志(电子版), 2013(23): 10691-10695.
|
| 33 |
Zhou JJ, Koska J, Bahn G, et al. Fasting glucose variation predicts microvascular risk in Accord and Vadt[J]. J Clin Endocrinol Metab, 2021, 106(4): 1150-1162.
|
| 34 |
Lu J, Ma X, Zhou J, et al. Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes[J]. Diabetes Care, 2018, 41(11): 2370-2376.
|
| 35 |
Mayeda L, Katz R, Ahmad I, et al. Glucose time in range and peripheral neuropathy in type 2 diabetes mellitus and chronic kidney disease[J]. BMJ Open Diabetes Res Care, 2020, 8(1): e000991.
|